IL-6 through its receptors of IL-6R (CD236) and glycoprotein 130 can activate the Janus kinases (JAK) and signal transducer and activator of transcription 3 (STAT3) signaling, enhancing liver fibrosis [23, 24]. This evidence concerns the gene GYPC and Hepatic fibrosis.